<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045445"><TermName>exemestane</TermName><TermPronunciation>(EK-seh-MEH-stayn)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat advanced breast cancer and to prevent recurrent breast cancer in postmenopausal women who have already been treated with tamoxifen. It is also being studied in the treatment of other types of cancer. Exemestane causes a decrease in the amount of estrogen made by the body. It is a type of aromatase inhibitor. Also called Aromasin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705474" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;exemestane&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705475" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;exemestano&quot;" language="es" id="_4"/><SpanishTermName>exemestano</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar el cáncer de mama avanzado y para prevenir el cáncer de mama recidivante en mujeres posmenopáusicas que ya fueron tratadas con tamoxifeno. También está en estudio para el tratamiento de otros tipos de cáncer. El exemestano produce una disminución en la cantidad de estrógeno que el cuerpo elabora. Es un tipo de inhibidor de la aromatasa. También se llama Aromasin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2008-01-28</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000492015">Exemestane</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
